High flow nasal oxygen
High flow nasal oxygen has been studied in 2 papers since 2022: 2 observational studies in people. The newest paper, May 19, 2023: “High flow nasal oxygen in frail COVID-19 patients hospitalized in intermediate care units and non-eligible to invasive mechanical ventilation”.
2 papers study it1 findingUpdated
“At day-30, 73% of patients were deceased, one patient (2%) was undergoing HFNO, 9% of patients were discharged from hospital.”
- 1 lab in 1 country
- Funder: Hospices Civils de Lyon
- Humans2
What is High flow nasal oxygen linked with?
1Studies link High flow nasal oxygen with 1 measure, most often mortality (1 study).
Mortality
upin humans1
1 study
Mortality
upin humans1
High flow nasal oxygen is associated with mortality in humans (severe COVID-19 pneumonia, non-eligible for IMV) (73% deceased at day-30).
“At day-30, 73% of patients were deceased, one patient (2%) was undergoing HFNO, 9% of patients were discharged from hospital.”
Humanssevere COVID-19 pneumonia, non-eligible for IMV7.5 daysn = 56
Respiratory medicine and research
Latest
Respiratory Medicine and Research
High flow nasal oxygen in frail COVID-19 patients hospitalized in intermediate care units and non-eligible to invasive mechanical ventilation
Cohort study of 56 peopleCOVID-19
Cureus
Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Patients in a Portuguese ICU
Case series of 227 peopleCOVID-19